Ifosfamide Powder, For Solution
NDC Package 21586-211-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ifosfamide (ifosfamide for injection) powders is ifosfamide is used to treat various cancers (such as testicular cancer). This formulation utilizes a powder, for solution delivery system. Marketed by Sterimax Inc., this product is identified by NDC 21586-211.

Identification & Billing

NDC Package Code
21586-211-02
Package Description
5 VIAL in 1 CARTON / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-211-01)
Product Code
21586-211
11-Digit Billing Format
21586021102

Clinical Specifications

Proprietary Name
Ifosfamide
Non-Proprietary Name
Ifosfamide For Injection
Substance Name
Ifosfamide
Dosage Form
Powder, For Solution - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
IFOSFAMIDE 1 g/1
Pharmacologic Class
Usage Information
Ifosfamide is used to treat various cancers (such as testicular cancer). It works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Sterimax Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE -
Start Marketing Date
09-04-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21586-211-02 identifies a specific commercial package of 5 vial in 1 carton / 1 powder, for solution in 1 vial (21586-211-01) of Ifosfamide, a human prescription drug labeled by Sterimax Inc.. This powder, for solution is formulated for intravenous use and contains ifosfamide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sterimax Inc. on September 04, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Ifosfamide is used to treat various cancers (such as testicular cancer). It works by slowing or stopping the growth of cancer cells.

How is this Sterimax Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21586021102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21586-211-02
11-Digit CMS (5-4-2)
21586-0211-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.